Stock Earnings

Question 1

Abcellera Biologics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Abcellera Biologics Incの総資産は$1,360で、純lossは$-162です。

Question 2

ABCLの主要な財務比率は何ですか？

Accepted Answer

Abcellera Biologics Incの流動比率は4.47、純利益率は-578.57、1株当たり売上高は$0.09です。

Question 3

Abcellera Biologics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Abcellera Biologics Inc largest revenue segment is Antibodies, at a revenue of 28,833,000 in the most earnings release.For geography, Canada is the primary market for Abcellera Biologics Inc, at a revenue of 26,200,000.

Question 4

Abcellera Biologics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Abcellera Biologics Incの純lossは$-162です。

Question 5

Abcellera Biologics Incに負債はありますか？

Accepted Answer

yes、Abcellera Biologics Incの負債は304です。

Question 6

Abcellera Biologics Incの発行済株式数は何株ですか？

Accepted Answer

Abcellera Biologics Incの総発行済株式数は295.75株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	35	28	38	485	375	233
Revenue Growth (YoY)	9%	-26%	-92%	28.99%	61%	2,018%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	85	85	75	66	48	15
Research & Development	182	167	175	107	62	29
Operating Expenses	296	343	275	268	170	77
Other Non Operating Income (Expenses)	7	58	17	10	17	8
Pretax Income	-204	-200	-174	239	219	157
Income Tax Expense	-33	-37	-27	80	65	38
Net Income	-171	-162	-146	158	153	118
Net Income Growth	-2%	11%	-192%	3%	30%	-6,000%
Shares Outstanding (Diluted)	298.87	294.32	289.16	314.8	318.3	269.5
Shares Change (YoY)	1%	2%	-8%	-1%	18%	1%
EPS (Diluted)	-0.57	-0.55	-0.5	0.5	0.48	0.44
EPS Growth	-4%	9%	-200.99%	4%	9%	-4,500%
Free Cash Flow	-153	-186	-121	204	186	8
Free Cash Flow Per Share	-0.51	-0.63	-0.41	0.64	0.58	0.02
Gross Margin	--	--	--	--	--	--
Operating Margin	-745.71%	-1,121.42%	-623.68%	44.53%	54.4%	66.95%
Profit Margin	-488.57%	-578.57%	-384.21%	32.57%	40.8%	50.64%
Free Cash Flow Margin	-437.14%	-664.28%	-318.42%	42.06%	49.6%	3.43%
EBITDA	-238	-224	-213	243	218	160
EBITDA Margin	-680%	-800%	-560.52%	50.1%	58.13%	68.66%
D&A For EBITDA	23	90	24	27	14	4
EBIT	-261	-314	-237	216	204	156
EBIT Margin	-745.71%	-1,121.42%	-623.68%	44.53%	54.4%	66.95%
Effective Tax Rate	16.17%	18.5%	15.51%	33.47%	29.68%	24.2%

Abcellera Biologics Inc (ABCL) Price

ABCL Stock Price Chart

ABCL Income

Follow-Up Questions